stars 1 stars 2 stars 3

Inbiotech Ltd. is a pharmaceutical company dedicated at providing high-quality healthcare by developing, manufacturing, and marketing affordable generic, branded generic, and Over-the Counter (OTC) pharmaceuticals. Headquartered in Sofia, the company has a successful track record in obtaining first-to-market approvals in Bulgaria for generic drugs in the cardiovascular, gastroenterology, and psychiatry therapeutic areas. The company employs a team of leading professionals with long-standing experience and proven expertise in the pharmaceutical industry. Inbiotech has a growing product portfolio which covers a variety of therapeutic areas, including proven medecines for the treatment of diseases such as hypertension, hyperlipidemia, ulcer disease of the stomach and duodenum, skeleton-muscular diseases, as well as a number of depressive diseases. Leading principles in our drug policy and strategy are the comprehensive research and analysis of the therapeutical and socio-economic effects of the project, combined with targeted marketing and management efforts to complete the cycle from science to successful market realization.

Inbiotech Questions

The Inbiotech annual revenue was $5 million in 2026.

Rod McPhee is the Director, Infectious Diseases of Inbiotech.

3 people are employed at Inbiotech.

Inbiotech is based in Sofia, Sofia-Capital.

The NAICS codes for Inbiotech are [32, 32541, 3254, 325].

The SIC codes for Inbiotech are [2834, 28, 283].

Top Inbiotech Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users